SCM

Stonepine Capital Management Portfolio holdings

AUM $114M
1-Year Est. Return 77.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$3.43M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1 +$272M
2 +$4.81M
3 +$3.92M
4
IKT icon
Inhibikase Therapeutics
IKT
+$2.57M
5
ACET icon
Adicet Bio
ACET
+$2.43M

Top Sells

1 +$3.74M
2 +$2.6M
3 +$2.51M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$2.28M
5
SRZN icon
Surrozen
SRZN
+$2.21M

Sector Composition

1 Healthcare 100%
2 Financials 0%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELDN icon
26
Eledon Pharmaceuticals
ELDN
$276M
$1.35M 1.07%
+893,100
MIST icon
27
Milestone Pharmaceuticals
MIST
$166M
$1.34M 1.06%
+662,666
OABI icon
28
OmniAb
OABI
$384M
$1.3M 1.03%
701,000
-1,441,857
QNRX
29
Quoin Pharmaceuticals
QNRX
$9.78M
$1.13M 0.89%
+78,189
LUNG icon
30
Pulmonx
LUNG
$67.2M
$1.07M 0.85%
486,400
-183,600
GERN icon
31
Geron
GERN
$744M
$1.06M 0.84%
805,800
-794,200
CBIO
32
Crescent Biopharma
CBIO
$479M
$1.04M 0.82%
+87,682
KZR
33
DELISTED
Kezar Life Sciences
KZR
$982K 0.78%
156,179
-227,003
EDSA icon
34
Edesa Biotech
EDSA
$61.6M
$976K 0.77%
687,500
BOLD
35
Boundless Bio
BOLD
$31.9M
$852K 0.67%
710,071
+296,618
RADX
36
Radiopharm Theranostics
RADX
$35.6M
$851K 0.67%
+51,000,000
SMLR
37
DELISTED
Semler Scientific
SMLR
$765K 0.6%
+50,000
MXCT icon
38
MaxCyte
MXCT
$129M
$727K 0.58%
469,018
+10,000
ANTX icon
39
AN2 Therapeutics
ANTX
$148M
$716K 0.57%
627,668
+63,755
GOSS icon
40
Gossamer Bio
GOSS
$46.6M
$635K 0.5%
204,770
ZNTL icon
41
Zentalis Pharmaceuticals
ZNTL
$282M
$626K 0.5%
463,700
+9,900
BIOA
42
BioAge Labs
BIOA
$722M
$595K 0.47%
45,000
-143,571
MNKD icon
43
MannKind Corp
MNKD
$1.07B
$490K 0.39%
86,359
-71,210
CGEN icon
44
Compugen
CGEN
$214M
$467K 0.37%
+305,400
CDXS icon
45
Codexis
CDXS
$245M
$417K 0.33%
256,106
+167,842
INAB icon
46
IN8bio
INAB
$15.8M
$386K 0.31%
164,893
+5,472
FENC icon
47
Fennec Pharmaceuticals
FENC
$339M
$385K 0.3%
+50,000
CABA icon
48
Cabaletta Bio
CABA
$611M
$375K 0.3%
+171,100
KTTA icon
49
Pasithea Therapeutics
KTTA
$23.1M
$355K 0.28%
+275,062
PLRX icon
50
Pliant Therapeutics
PLRX
$73.7M
$281K 0.22%
230,050
-59,187